These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37527538)

  • 1. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
    Li Z; Dai R; Chen M; Huang L; Zhu K; Li M; Zhu W; Li Y; Xie N; Li J; Wang L; Lan F; Cao CM
    Cardiovasc Res; 2023 Nov; 119(14):2421-2440. PubMed ID: 37527538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
    Zhang Y; Lv F; Jin L; Peng W; Song R; Ma J; Cao CM; Xiao RP
    Cardiovasc Res; 2011 Jul; 91(1):108-15. PubMed ID: 21285295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1.
    Wang X; Zhu H; Zhang X; Liu Y; Chen J; Medvedovic M; Li H; Weiss MJ; Ren X; Fan GC
    Cardiovasc Res; 2012 May; 94(2):379-90. PubMed ID: 22354898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H
    Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP
    Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.
    Luedde M; Lutz M; Carter N; Sosna J; Jacoby C; Vucur M; Gautheron J; Roderburg C; Borg N; Reisinger F; Hippe HJ; Linkermann A; Wolf MJ; Rose-John S; Lüllmann-Rauch R; Adam D; Flögel U; Heikenwalder M; Luedde T; Frey N
    Cardiovasc Res; 2014 Jul; 103(2):206-16. PubMed ID: 24920296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MG53 constitutes a primary determinant of cardiac ischemic preconditioning.
    Cao CM; Zhang Y; Weisleder N; Ferrante C; Wang X; Lv F; Zhang Y; Song R; Hwang M; Jin L; Guo J; Peng W; Li G; Nishi M; Takeshima H; Ma J; Xiao RP
    Circulation; 2010 Jun; 121(23):2565-74. PubMed ID: 20516375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma exosomes generated by ischaemic preconditioning are cardioprotective in a rat heart failure model.
    Luo Z; Hu X; Wu C; Chan J; Liu Z; Guo C; Zhu R; Zhang L; Zhang Y; Jin S; He S
    Br J Anaesth; 2023 Jan; 130(1):29-38. PubMed ID: 36347723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the washout period in preconditioning.
    Salie R; Lochner A; Loubser DJ
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat5-dependent cardioprotection in late remote ischaemia preconditioning.
    Chen H; Jing XY; Shen YJ; Wang TL; Ou C; Lu SF; Cai Y; Li Q; Chen X; Ding YJ; Yu XC; Zhu BM
    Cardiovasc Res; 2018 Apr; 114(5):679-689. PubMed ID: 29365089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection by the transfer of coronary effluent from ischaemic preconditioned rat hearts: identification of cardioprotective humoral factors.
    Maciel L; de Oliveira DF; Verissimo da Costa GC; Bisch PM; Nascimento JHM
    Basic Res Cardiol; 2017 Sep; 112(5):52. PubMed ID: 28695353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin mediates cardioprotection against aging-induced ischemic necroptosis.
    Li C; Mu N; Gu C; Liu M; Yang Z; Yin Y; Chen M; Wang Y; Han Y; Yu L; Ma H
    Aging Cell; 2020 Feb; 19(2):e13096. PubMed ID: 31944526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of circulating microvesicles derived from ischemic preconditioning on myocardial ischemia/reperfusion injury in rats by inhibiting endoplasmic reticulum stress.
    Liu M; Wang Y; Zhu Q; Zhao J; Wang Y; Shang M; Liu M; Wu Y; Song J; Liu Y
    Apoptosis; 2018 Aug; 23(7-8):436-448. PubMed ID: 29980896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate Early Response Gene X-1 (IEX-1) Mediates Ischemic Preconditioning-Induced Cardioprotection in Rats.
    Xu MJ; Cai Y; Qu A; Shyy JY; Li W; Wang X
    Oxid Med Cell Longev; 2017; 2017():6109061. PubMed ID: 29213350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning.
    Lankford AR; Yang JN; Rose'Meyer R; French BA; Matherne GP; Fredholm BB; Yang Z
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1469-73. PubMed ID: 16299262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.
    Talukder MA; Yang F; Shimokawa H; Zweier JL
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H437-45. PubMed ID: 20525875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury.
    Wang Q; Park KH; Geng B; Chen P; Yang C; Jiang Q; Yi F; Tan T; Zhou X; Bian Z; Ma J; Zhu H
    Front Cardiovasc Med; 2022; 9():868632. PubMed ID: 35711363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
    Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
    J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.